i
Rapid increase in ivermectin prescriptions and reports of severe illness associated with use of products containing ivermectin to prevent or treat COVID-19
-
August 26, 2021
-
Series: HAN ; 449
[PDF-222.15 KB]
Details:
-
Corporate Authors:
-
Description:Distributed via the CDC Health Alert Network
August 26, 2021, 11:40 AM ET CDCHAN-00449
Ivermectin is a U.S. Food and Drug Administration (FDA)-approved prescription medication used to treat certain infections caused by internal and external parasites. When used as prescribed for approved indications, it is generally safe and well tolerated.
During the COVID-19 pandemic, ivermectin dispensing by retail pharmacies has increased, as has use of veterinary formulations available over the counter but not intended for human use. FDA has cautioned about the potential risks of use for prevention or treatment of COVID-19.
Ivermectin is not authorized or approved by FDA for prevention or treatment of COVID-19. The National Institutes of Health’s (NIH) COVID-19 Treatment Guidelines Panel has also determined that there are currently insufficient data to recommend ivermectin for treatment of COVID-19. ClinicalTrials.gov has listings of ongoing clinical trials that might provide more information about these hypothesized uses in the future.
Adverse effects associated with ivermectin misuse and overdose are increasing, as shown by a rise in calls to poison control centers reporting overdoses and more people experiencing adverse effects.
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Place as Subject:
-
Issue:449
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
